Skip to main content
SpringerLink
Log in

Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Porphyrins are interesting derivatives with low toxicity, tumor avidity and rapid wash-out suggested as potential radiopharmaceuticals in radiolabeled form. In this work, [166Ho] labeled 5,10,15,20-tetrakis(phenyl) porphyrin ([166Ho]-TPP) was prepared using [166Ho]HoCl3 and 5,10,15,20-tetrakis(phenyl)porphyrin (H2TPP) for 12 h at 50 °C (radiochemical purity: >95 ± 2 % ITLC, >99 ± 0.5 % HPLC, specific activity: 0.9–1.1 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 48 h. The partition coefficient was calculated for the compound (log P = 2.01). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and SPECT. A detailed comparative pharmacokinetic study performed for 166Ho cation and [166Ho]-TPP performed up to 24 h. The complex is mostly washed out from the circulation through kidneys and in less extends from the liver. The kidney:blood, kidney:liver and kidney:muscle ratios 4 h post injection were 14, 3.6 and 7.38 respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Thomas SR, Khuntia D (2007) Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer. Int J Nanomed 2:79–87

    Article  CAS  Google Scholar 

  2. Kahl SB, Koo MS (1992) Synthesis and properties of tetrakiscarborane-carboxylate esters of 2,4-bis (-dihydroxyethyl) deuteroporphyrin IX. In: Allen BJ, Moore DE, Harrington BV (eds) Progress in neutron capture therapy for cancer. Plenum Press, New York, pp 223–226

    Chapter  Google Scholar 

  3. Sasaki K, Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S-I (2001) Pharmacokinetic study of a indium-porphyrin photo- and sono-sensitizer in tumor-bearing mice. ATX-70. Jpn J Cancer Res 92:989–995

    Article  CAS  Google Scholar 

  4. Fawwaz RA, Frye F, Loughman WD, Hemphill W (1974) Survival of skin homografts in dogs injected with 109Pd-protoporphyrin. J Nucl Med 15:997–1002

    CAS  Google Scholar 

  5. Fawwaz RA, Hemphill W, Winchell HS (1971) Potential use of 109Pd-porphyrin complexes for selective lymphatic ablation. J Nucl Med 12:231–236

    CAS  Google Scholar 

  6. Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M (2007) Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy. Q J Nucl Med Mol Imaging 15:16–23

    Google Scholar 

  7. Sarma HD, Das T, Banerjee S, Venkatesh M, Vidyasagar PB, Mishra KP (2010) Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor model. Cancer Biother Radiopharm 25:47–54

    Article  CAS  Google Scholar 

  8. Murugesan S, Shettyc SJ, Srivastava TS, Noronha OPD, Samuel AM (2001) A technetium-99m-labelled cyclam acid porphyrin (CAP) for tumour imaging. Appl Radiat Isot 55:641–646

    Article  CAS  Google Scholar 

  9. Wang A-Y, Lin J-L, Lin W-C (2010) Studies on the porphine labeled with 99mTc-pertechnetate. J Radioanal Nucl Chem 284:121–128

    Google Scholar 

  10. Nunn AD (1978) Medical radionuclides and the quality of radiopharmaceuticals, The kinetics of incorporation of 111In into m-tetraphenylporphine. J Radioanal Nucl Chem 53:291–298

    Google Scholar 

  11. Fazaeli Y, Jalilian AR, Amini MM, Rahiminejad-kisomi A, Rajabifar S, Bolourinovin F, Moradkhani S (2011) Preparation and preliminary evaluation of [67Ga]–tetra phenyl porphyrin complexes as possible imaging agents. J Radioanal Nucl Chem 288:17–24

    Article  CAS  Google Scholar 

  12. Louis E, Boverie J, Dewit O, Baert F, De Vos M, D’Haens G, Belgian IBD Research Group (2007) Treatment of small bowel subocclusive Crohn’s disease with infliximab: an open pilot study. Acta Gastroenterol Belg 70(1):15–19

    Google Scholar 

  13. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC (2007) Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 132(6):1949–1953

    Article  Google Scholar 

  14. Zielhuis SW, Nijsen JF, de Roos R, Krijger GC, van Rijk PP, Hennink WE, van het Schip AD (2006) Int J Pharm 31:69–74

    Article  Google Scholar 

  15. Huh R, Park YS, Lee JD, Chung YS, Park YG, Chung SS, Chang JW (2005) Yonsei Med J 46:51–60

    Article  CAS  Google Scholar 

  16. Seong SK, Ryu JM, Shin DH, Bae EJ, Shigematsu A, Hatori Y, Nishigaki J, Kwak C, Lee SE, Park KB (2005) Eur J Nucl Med Mol Imaging 32:910–917

    Article  CAS  Google Scholar 

  17. Kropácek M, Melichar F, Henková K, Konopková M (2003) Nucl Med Rev Cent East Eur. 6(1):1–4

    Google Scholar 

  18. Breitz H, Wendt R, Stabin M, Bouchet L, Wessels B (2003) Dosimetry of high dose skeletal targeted radiotherapy (STR) with 166Ho-DOTMP. Cancer Biother Radiopharm. 18(2):225–230

    Article  CAS  Google Scholar 

  19. Joh CW, Park CH, Kang HJ, Oh YT, Chun, Kim HS, Choi BI, Park KB, Kim YM, Kim KH, Vahc YW, Jang JS, Lee BK (2000) Nucl Med Commun 21(10):959–964

    Article  CAS  Google Scholar 

  20. Majali MA, Saxena SK, Joshi SH, Unni PR, Ramamoorthy N (2001) Nucl Med Commun 22:97–103

    Article  CAS  Google Scholar 

  21. Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S (2009) Nucl Med Commun 30:362–367

    Article  Google Scholar 

  22. Chung YL, Lee JD, Bang D, Lee JB, Park KB, Lee MG (2000) Eur J Nucl Med 27:842–846

    Article  CAS  Google Scholar 

  23. Falk JE (1975) Porohyrins and metalloporphyrins. Elsevier Science Publishing, New York

    Google Scholar 

  24. Manual for reactor produced radioisotopes, IAEA, VIENNA, 2003, IAEA-TECDOC-1340, ISBN 92-0-101103-2, ISSN 1011–4289, © IAEA, 2003, pp. 71, Printed by the IAEA in Austria, January 2003

  25. Adler AD, Longo FR, Finarelli JD, Goldmacher J, Assour J, Korsakoff L (1967) A simplified synthesis for meso-tetraphenylporphine. J Org Chem 32:476

    Article  CAS  Google Scholar 

  26. Jalilian AR, Rowshanfarzad P, Sabet M, Novinrooz A, Raisali G (2005) Preparation of [66Ga]bleomycin complex as a possible PET radiopharmaceutical. J Radioanal Nucl Chem 264:617

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Nuclear Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

    Nassim Vahidfar & Ali Khalaj

  2. Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), P.O. Box 14395-836, Tehran, Iran

    Amir R. Jalilian, Yousef Fazaeli & Ali Bahrami-Samani

  3. Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Davood Beiki

Authors
  1. Nassim Vahidfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amir R. Jalilian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yousef Fazaeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Bahrami-Samani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Davood Beiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ali Khalaj
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amir R. Jalilian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vahidfar, N., Jalilian, A.R., Fazaeli, Y. et al. Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent. J Radioanal Nucl Chem 295, 979–986 (2013). https://doi.org/10.1007/s10967-012-2034-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-012-2034-1

Keywords

Search

Navigation